Aquestive Therapeutics, Inc. (AQST) › RevenueAquestive Therapeutics, Inc. (AQST) — RevenueAnnual figures by period end, from SEC filings.2018-12-31: $67.43M2019-12-31: $52.61M2020-12-31: $45.85M2021-12-31: $50.83M2022-12-31: $47.68M2023-12-31: $50.58M2024-12-31: $57.56M2025-12-31: $44.55M$44.55M2018-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$44.55M-22.6%2026-03-04From 2025-01-012024-12-31$57.56M+13.8%2026-03-04From 2024-01-012023-12-31$50.58M+6.1%2025-03-05From 2023-01-012022-12-31$47.68M-6.2%2024-03-05From 2022-01-012021-12-31$50.83M+10.9%2023-03-31From 2021-01-012020-12-31$45.85M-12.8%2022-03-08From 2020-01-012019-12-31$52.61M-22.0%2021-03-09From 2019-01-012018-12-31$67.43M—2020-03-11From 2018-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)